Prophylactic systemic antibiotics to reduce morbidity and mortality in neonates with central venous catheters
- PMID: 18254094
- PMCID: PMC8916088
- DOI: 10.1002/14651858.CD006179.pub2
Prophylactic systemic antibiotics to reduce morbidity and mortality in neonates with central venous catheters
Abstract
Background: The use of central venous catheters is recognised as a risk factor for nosocomial infection. Prophylactic antibiotics may be effective in preventing catheter-related blood stream infection in newborns but may also have the undesirable effect of promoting the emergence of resistant strains of micro-organisms.
Objectives: To determine the effect of prophylactic antibiotics on mortality and morbidity in neonates with central venous catheters.
Search strategy: Searches were done of the Cochrane Neonatal Review Group Specialised Register, MEDLINE from 1950 to April 2007, CINAHL from 1982 to April 2007, and the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, Issue 2 2007). Previous reviews (including cross references) were also searched.
Selection criteria: Randomised controlled trials or quasi-randomised controlled trials of adequate quality in which either individual newborn infants or clusters of infants were randomised to receive prophylactic antibiotics (not including antifungals) versus placebo or no treatment. Infants must have had central venous catheters, been full term infants less than 28 days old or preterm infants up to 44 weeks (postmenstrual) corrected age.
Data collection and analysis: Criteria and methods used to assess the methodological quality of the trials: standard methods of the Cochrane Collaboration and its Neonatal Review Group were used. The review authors extracted data independently. Attempts were made to contact study investigators for additional information as required.
Main results: Three small studies have been included in this review. Prophylactic antibiotics in neonates with central venous catheters had no effect on overall mortality (typical RR 0.68, 95% confidence interval 0.31, 1.51). Prophylactic antibiotics in neonates with central venous catheters decreased the rate of proven bacterial sepsis (typical RR 0.38, 95% confidence interval 0.18, 0.82). Prophylactic antibiotics in neonates with central venous catheters decreased the rate of suspected or proven bacterial septicaemia (typical RR 0.40, 95% confidence interval 0.20, 0.78). No resistant organisms colonising infants were identified in any of the studies. No pooled data were available for other important outcome measures such as chronic lung disease or neurodevelopmental outcome.
Authors' conclusions: Prophylactic systemic antibiotics in neonates with a central venous catheter reduces the rate of proven or suspected septicaemia. However, this may not be clinically important in the face of no significant difference in overall mortality and the lack of data on long-term neurodevelopmental outcome. Furthermore, there is a lack of data pertaining to the potentially significant disadvantages of this approach such as the selection of resistant organisms. The routine use of prophylactic antibiotics in infants with central venous catheters in neonatal units cannot currently be recommended.
Conflict of interest statement
None
Figures
Update of
- doi: 10.1002/14651858.CD006179
References
References to studies included in this review
Cooke 1997 {published and unpublished data}
-
- Cooke RWI, Nycyk A, Okuonghuae H, Shah V, Damjanovic V, Hart CA. Low‐dose vancomycin prophlyaxis reduces coagulase‐negative staphylococcal bacteraemia in very low birth weight infants. Journal of Hospital Infection 1997;37(4):297‐303. - PubMed
Harms 1995 {published data only}
-
- Harms K, Herting E, Kron M, Schiffmann H, Schulz‐Ehlbeck H. Randomized, controlled trial of amoxicillin prophylaxis for prevention of catheter‐related infections in newborn infants with central venous silicone elastomer catheters. The Journal of Pediatrics 1995;127(4):615‐9. - PubMed
Spafford 1994 {published data only}
-
- Spafford PS, Sinkin RA, Cox C, Reubens L, Powell KR. Prevention of central venous catheter‐realted coagulase‐negative staphylococcal sepsis in neonates. The Journal of Pediatrics 1994;125(2):259‐63. - PubMed
References to studies excluded from this review
Baier 1998 {published data only}
-
- Baier RJ, Bocchini JA Jr, Brown EG. Selective use of vancomycin to prevent coagulase‐negative staphylyococcal nasocomial bacteremia in high risk very low birth weight infants. The Pediatric Infectious Disease Journal 1998;17(3):179‐83. - PubMed
Garland 2005 {published data only}
-
- Garland JS, Alex CP, Henrickson KJ, McAuliffe TL, Maki DG. A vancomycin‐heparin lock solution for the prevention of nosocomial bloodstream infection in critically ill neonates with peripherally inserted central venous catheters: a prospective, randomised trial. Pediatrics 2005;116:e198‐205. - PubMed
Kacica 1994 {published data only}
-
- Kacica MA, Horgan MJ, Ochoa L, Sandleer R, Lepw ML, Venezia RA. Prevention of gram‐positive sepsis in neonates weighing less than 1500 grams. The Journal of Pediatrics 1994;125(2):253‐8. - PubMed
Moller 1993 {published data only}
-
- Moller JC, Rossa M, Nachtrodt G, Richter A, Tegtmeyer FK. Preventive antibiotic administration for prevention of nosocomial septicemia in very small premature infants (VLBW infants) [Praventive antibiotikagabe zur verhinderung nosokomialer septikamien bei sehr kleinen frugeborenen (VLBW infants)]. Klinische Padiatrie 1993;205:140‐4. - PubMed
Rackoff 1995 {published data only}
-
- Rackoff WR, Weiman M, Jakobowski D, Hirschl R, Stallings V, Bilodeau J, Danz P, et al. A randomised, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children. The Journal of Pediatrics 1995;127(1):147‐51. - PubMed
References to studies awaiting assessment
Graham 2003 {published data only}
-
- Graham A, Finer NN. Vancomycin flush technique to prevent coagulase negative staphylococcus infection in VLBW infants: a prospective placebo‐controlled randomized trial. Pediatric Academic Societies Abstract Archive 2000 ‐ 2006. 2003:2120.
Additional references
Abeywardana 2006
-
- Abeywardana, Samanthi. Report of the Australian and New Zealand Neonatal Network 2004. Sydney: ANZNN, 2006:54.
Adams‐Chapman 2002
-
- Adams‐Chapman I, Stoll BJ. Prevention of nosocomial infections in the neonatal intensive care unit. Current Opinion in Pediatrics 2002;14:157‐64. - PubMed
Apostolopoulou 2004
-
- Apostolopoulou E, Lambridou M, Lambadaridis I. Nosocomial bloodstream infections in a neonatal intensive care unit. British Journal of Nursing 2004;13:806‐12. - PubMed
Chien 2002
-
- Chien L, Macnab Y, Aziz K, Andrews W, McMillan DD, Lee SK, Canadian Neonatal Network. Variations in central venous catheter‐related infection risks among Canadian neonatal intensive care units. Pediatric Infectious Disease Journal 2002;21:505‐11. - PubMed
Cruccetti 2003
-
- Cruccetti A, Pierro A, Uronen H, Klein N. Surgical infants on total parenteral nutrition have impaired cytokine responses to microbial challenge. Journal of Pediatric Surgery 2003;38:138‐42. - PubMed
Dear 1999
-
- Dear P. Infection in the newborn. In: Rennie JM, Roberton NRC editor(s). Textbook of Neonatology. 3rd Edition. Edinburgh: Churchill Livingstone, 1999:1109‐1202.
Freij 1999
-
- Freij BJ, McCracken Jr GH. Acute infections. In: Avery GB, Fletcher MA, MacDonald MG editor(s). Neonatology: pathophysiology and management of the newborn. 5th Edition. Philadelphia: Lippincott Williams & Wilkins, 1999:1189‐1230.
Haas 2003
-
- Haas NA, Haas SA. Central venous catheter techniques in infants and children. Current Opinion in Anaesthesiology 2003;16:291‐303. - PubMed
Henrickson 2000
-
- Henrickson KJ, Axtell RA, Hoover SM, Kuhn SM, Pritchett J, Kehl SC, et al. Prevention of central venous catheter‐related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: A randomized, multicenter double‐blind trial. Journal of Clinical Oncology 2000;18:1269‐78. - PubMed
Hodge 2002
Inglis 2004
Inglis 2005
Isaacs 2000
Isaacs 2003
Liljedahl 2004
-
- Liljedahl M, Bodin L, Schollin J. Coagulase‐negative staphylococcal sepsis as a predictor of bronchopulmonary dysplasia. Acta Pædiatrica 2004;93:211‐5. - PubMed
McGuire 2004
Nagata 2002
-
- Nagata E, Brito ASJ, Matsuo T. Nosocomial infections in a neonatal intensive care unit: incidence and risk factors. American Journal of Infection Control 2002;30:26‐31. - PubMed
O'Grady 2002
-
- O'Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Maki DG, et al. Guidelines for the prevention of intravascular catheter‐related infections. The Hospital Infection Control Practices Advisory Committee, Centers for Disease Control and Prevention. Pediatrics 2002;110:e51. - PubMed
Ogawa 1999
-
- Ogawa Y, Shimizu H, Takasaki J, Nakamura T. Strategy for the prevention and treatment of chronic lung disease of the premature infant. Pediatric Pulmonology Supplement 1999;18:212‐5. - PubMed
Shaul 1998
-
- Shaul DB, Scheer B, Rokhsar S, Jones VA, Chan LS, Boody BA, et al. Risk factors for early infection of central venous catheters in pediatric patients. Journal of the American College of Surgeons 1998;186:654‐8. - PubMed
Stoll 2002
-
- Stoll BJ, Hansen N, Fanaroff AA, Wright, LL, Carlo WA, Ehrenkranz JA, et al. Late‐onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002;110:285‐91. - PubMed
Stoll 2004
-
- Stoll BJ, Hansen NI, Adams‐Chapman I, Fanaroff AA, Hintz SR, Vohr B, et al. Neurodevelopmental and growth impairment among extremely low‐birth‐weight infants with neonatal infection. JAMA 2004;292:2357‐65. - PubMed
Van Marter 2002
-
- Marter LJ, Dammann O, Allred EN, Leviton A, Pagano M, Moore M, et al. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. Journal of Pediatrics 2002;140:171‐6. - PubMed
Viudes 2002
-
- Viudes A, Pemán J, Cantón E, Úbeda P, López‐Ribot JL, Gobernado M. Candidemia at a tertiary‐care hospital: epidemiology, treatment, clinical outcome and risk factors for death. European Journal of Clinical Microbiology and Infectious Diseases 2002;21:767‐74. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
